- 21 September
-
On September 11–17, 2026, Ekaterinburg hosted the International Youth Festival, a large-scale event that brought together 10,000 young leaders from 191 countries. At the festival running under the motto «Follow Your Dream,» the Medsintez Plant presented its exhibition, showcasing the achievements of the Ural pharmaceutical industry in the field of import substitution.
- 18 September
-
The updated clinical guidelines for treatment of ARVI in children took effect on September 2, 2026. The document was developed by leading experts from the Union of Pediatricians of Russia, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and the Russian Society of Emergency Medical Care and approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. It fundamentally shifts therapeutic approaches toward enhanced safety and minimal drug burden.
- 14 September
-
On September 3–4, 2026, Nizhny Novgorod hosted the 2nd Regional Endocrinological Congress: Challenges and Prospects of the Volga Region, with the active participation of the Medsintez Plant. As a strategic company, Medsintez Plant has been ensuring Russia's pharmaceutical security for 25 years. Company's exhibition booth showcased a range of hormonal medications for treatment of type 1 and type 2 diabetes, as well as drugs for infertility treatment through the IVF method.
- 04 September
-
More than twenty years ago, the Regiony Rossii (Regions of Russia, RR) magazine witnessed the birth of an innovative pharmaceutical production facility in Novouralsk, which had no analogues in the country. Today, the Medsintez Plant is a strategic asset in terms of national pharmaceutical security, a recognized industry leader, a National Champion, and a winner of prestigious awards. The secret behind the success of the Ural school of pharmaceuticals and biotechnology is explored in this article by RR.
- Home
- Cluster members
- UME Vektor
UME Vektor
At present, UME Vektor is a modern enterprise with a powerful production potential, a wide range of advanced technologies, a high professional level of personnel, and a well-established product quality control system.
Physiotherapy device Nov-M
Medical device Nov-M is a physiotherapy device that uses electromagnetic radiation and magnetic fields. The device is intended for use in research and medical institutions, as well as for home treatment.
The device operates in two main modes: microwave therapy and magnetic therapy.
The microwave module of the device is used for the prevention and treatment of diseases of the upper respiratory tract: bronchial asthma, bronchitis, laryngitis.
The magnetic module is used for a wide range of diseases: joints, skin, pelvic organs, nervous system, as well as surgical diseases.
The device has the following specifications:
– carrier frequency of electromagnetic radiation of the microwave therapy module (4,20 ± 0,05) ГГц;
– frequency deviation of the electromagnetic radiation generated by the device by the microwave therapy module is at least 25 MHz;
– electromagnetic energy flux density at a distance of 5 cm from the device antenna has a level of 5 to 20 μW/cm2;
– induction of magnetic fields generated by the magnetic belt of the device has a level not exceeding 15 mT;
– the device provides indication and alarm: the presence of mains power supply, a constant supply voltage of 5 V, a constant supply voltage of 15 V – by steady light of yellow indicators, switching on the operating mode of individual elements of the device – by steady light of green indicators, malfunctions of individual elements of the device – by steady light of blue indicators, the end of the procedure – by steady light of blue indicator and sound alarm 10 seconds before the end of therapy;
– the device provides information on the display: therapy mode selection (microwave or magnetic), selection of the duration of the procedure (for microwave: 2, 4, 6, 8, 10 minutes, for magnetic: 4, 8, 12, 16, 24, 28 minutes), countdown of the procedure time;
– the device provides automatic shutdown of the operating mode of the procedure after the expiration of the procedure time;
– the time for setting the operating mode of the device after switching on does not exceed 1 s.
– the weight of the device does not exceed 5 kg;
– overall dimensions of the device (without accessories) no more than 280 x 260 x 180 mm;
– the device operates from AC mains with a frequency of 50 Hz and a rated voltage of 220 V with mains voltage deviations of ± 10% of the rated value;
Warranty period – 12 months
Company Contacts:
28, Gagarina St., Ekaterinburg, 620078, Russia
Tel.: (343) 375-42-20, 374-04-33
Fax: (343) 374-15-91, 349-50-51
E-mail: vektor@vektor.ru
Web site: www.vektor.ru
